Steve Aselage - Nov 5, 2021 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Director
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
Nov 5, 2021
Transactions value $
-$100,000
Form type
4
Date filed
11/9/2021, 03:05 PM
Previous filing
Nov 3, 2021
Next filing
Nov 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Options Exercise $162K +10K +6.18% $16.23 172K Nov 5, 2021 Direct
transaction TVTX Common Stock Sale -$262K -10K -5.82% $26.23 162K Nov 5, 2021 Direct F1
holding TVTX Common Stock 19.5K Nov 5, 2021 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TVTX Employee stock option (right to buy) Options Exercise $0 -10K -12.5% $0.00 70K Nov 5, 2021 Common Stock 10K $16.23 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to an automatic trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2 The shares are held in the name of the Aselage Family Trust.
F3 The stock option is fully vested and exercisable.